Richter receives positive feedback for new contraceptive

Pharma

LaMography/Moni Lazar

Hungarian pharmaceutical company Gedeon Richter and Belgian peer Mithra Pharmaceuticals have said the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for a new combined oral contraceptive containing 15 mg estetrol (E4) and 3mg drospirenone (DRSP), according to an announcement on the website of the Budapest Stock Exchange. 

Subject to approval by the European Commission, the marketing authorization valid for the European Union is expected to be granted by the end of Q2 2021, the companies said. 

Richter will market the product in Europe under the brand name Drovelis. The company announced a partnership with Mithra in September 2018 to sell the oral contraceptive in Europe, Russia and other CIS countries under a different brand name. Mithra sells the contraceptive under the Estelle brand.

Oral contraceptives are Richter's top-selling products.

ADVERTISEMENT

Századvég raises GDP forecast to 7.8% Analysis

Századvég raises GDP forecast to 7.8%

Opposition parties to begin PM candidate primaries Elections

Opposition parties to begin PM candidate primaries

New editor-in-chief at Betone Studio Appointments

New editor-in-chief at Betone Studio

Budapest leaders make public transport free for under-14s City

Budapest leaders make public transport free for under-14s

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.